This stock has been showing accelerated earnings and very strong EPS growth. The price is also showing good strength, it has been trending up since mid-December. Price is above 50 and 20 ema, both the ema's are slanting upwards. Institutions have also increased their holdings. This stock has a very healthy mix of sales growth, EPS growth, profit growth and ROE of 20%. All of these combinations make it a strong case to purchase this stock.